Recruiting NA INTERVENTIONAL 2-arm NCT06308757

Role of the Very Low Calorie Ketogenic Diet (VLCKD) in Patients With Non-Alcoholic Steatohepatitis (NASH) With Fibrosis (KETONASH)

The Role of Very Low Calorie Ketogenic Diet (VLCKD) in Patients Affected by Non-Alcoholic Steatohepatitis (NASH) With Significant Fibrosis (KETONASH)

Sponsor: University of Bologna

Conditions Liver Fibrosis NAFLD NASH Obesity

Interventions Mediterranean low-calorie diet (LCD) Very-low-calorie ketogenic diet (VLCKD) with meal replacements

Updated 3 times since 2024 Last updated: Mar 13, 2024 Started: Sep 29, 2021 Primary completion: Nov 24, 2024 Completion: Dec 12, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Liver Fibrosis and NAFLD and is currently actively recruiting participants. University of Bologna leads this study, which shows 3 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Apr 2024 — Jul 2024 [monthly]

Recruiting NA

First recorded

Sep 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Bologna

Data source: University of Bologna

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bologna, Italy